Literature DB >> 20471965

Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.

Roxanne Sterniczuk1, Richard H Dyck, Frank M Laferla, Michael C Antle.   

Abstract

Circadian disturbances, including a fragmented sleep-wake pattern and sundowning, are commonly reported early in the progression of Alzheimer's disease (AD). These changes are distinctly different from those observed in non-pathological aging. Transgenic models of AD are a promising tool in understanding the underlying mechanisms and cause of disease. A novel triple-transgenic model of AD, 3xTg-AD, is the only model to exhibit both Abeta and tau pathology, and mimic human AD. The present study characterized changes pertaining to circadian rhythmicity that occur prior to and post-AD pathology. Both male and female 3xTg-AD mice demonstrated alterations to their circadian pacemaker with decreased nocturnal behavior when compared to controls. Specifically, males showed greater locomotor activity during the day and shorter freerunning periods prior to the onset of AD-pathology, and females had a decrease in activity levels during their typical active phase. Both sexes did not differ in terms of their freerunning periods or photic phase shifting ability. A decrease in vasoactive intestinal polypeptide-containing and vasopressin-containing cells was observed in the suprachiasmatic nucleus of 3xTg-AD mice relative to controls. This study demonstrates that abnormalities in circadian rhythmicity in 3xTg-AD mice precede expected AD pathology. This suggests that human studies may wish to determine if similar circadian dysfunction is predictive of early-onset AD. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471965     DOI: 10.1016/j.brainres.2010.05.013

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  73 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Neurodegeneration: amyloid awakenings.

Authors:  Moheb Costandi
Journal:  Nature       Date:  2013-05-23       Impact factor: 49.962

Review 3.  Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.

Authors:  Md Sahab Uddin; Dewan Md Sumsuzzman; Philippe Jeandet; Tapan Behl; Abdur Rauf; Md Shah Amran; Ghulam Md Ashraf
Journal:  Neurochem Res       Date:  2021-04-19       Impact factor: 3.996

Review 4.  Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-07-15       Impact factor: 3.911

Review 5.  Linking neural activity and molecular oscillations in the SCN.

Authors:  Christopher S Colwell
Journal:  Nat Rev Neurosci       Date:  2011-09-02       Impact factor: 34.870

Review 6.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

Review 7.  The missing link between sleep disorders and age-related dementia: recent evidence and plausible mechanisms.

Authors:  Feng Zhang; Rujia Zhong; Song Li; Raymond Chuen-Chung Chang; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2017-02-10       Impact factor: 3.575

8.  Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease.

Authors:  Jodi R Paul; Hira A Munir; Thomas van Groen; Karen L Gamble
Journal:  Neurobiol Dis       Date:  2018-03-11       Impact factor: 5.996

9.  Manipulations of amyloid precursor protein cleavage disrupt the circadian clock in aging Drosophila.

Authors:  Matthew R Blake; Scott D Holbrook; Joanna Kotwica-Rolinska; Eileen S Chow; Doris Kretzschmar; Jadwiga M Giebultowicz
Journal:  Neurobiol Dis       Date:  2015-03-10       Impact factor: 5.996

Review 10.  Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Authors:  Thomas L Platt; Valerie L Reeves; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.